Observational registry of chronic kidney diseases in China
A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases
This study is trying to learn more about chronic kidney disease in China by looking at how it affects people’s health and lives, using information from patients, those at risk, and healthy volunteers.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 90000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Guangdong Provincial People's Hospital Academic / other |
| Locations | 8 sites (Foshan, Guangdong and 7 other locations) |
| Trial ID | NCT05188885 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate the occurrence, development, treatment, prognosis, and related risk factors of chronic kidney disease (CKD) within the mainland Chinese population. It utilizes a multi-center approach to gather real-world data, allowing for a comprehensive analysis of CKD's impact on health and the economy. The study will include a diverse group of participants, including diagnosed CKD patients, individuals with risk factors, and healthy volunteers, to ensure a robust dataset for analysis. By establishing a standardized data network, the study seeks to enhance data collection and integration across multiple centers.
Who should consider this trial
Good fit: Ideal candidates include patients diagnosed with CKD, those with risk factors such as hypertension or diabetes, and healthy individuals willing to participate.
Not a fit: Patients who are unsuitable for enrollment as determined by the study physician will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved prevention and management strategies for chronic kidney disease in China.
How similar studies have performed: While similar observational studies have been conducted, this study aims to fill a gap in real-world data specific to the Chinese population, making it a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with CKD as defined in the KDIGO Clinical Practice Guidelines for the Evaluation and Management of Chronic Kidney Disease 2012 Edition; * Non-CKD patients with hypertension, diabetes, hyperlipidemia, hyperuricemia, eGFR (CKD-EPI formula) of 60-89 ml/min/1.73m\^2 and other risk factors for CKD; * Healthy population. * Signed the informed consent voluntarily. Exclusion Criteria: 。Patients identified to be unsuitable for enrollment by the study physician.
Where this trial is running
Foshan, Guangdong and 7 other locations
- The Second People's Hospital of Nanhai District in Foshan City — Foshan, Guangdong, China (Not_yet_recruiting)
- Guangdong Provincial Peoples Hospital — Guangzhou, Guangdong, China (Recruiting)
- The First Affiliated Hospital of Sun Yat-sen University — Guangzhou, Guangdong, China (Not_yet_recruiting)
- Wuhua County People's Hospital — Meizhou, Guangdong, China (Not_yet_recruiting)
- Fogang County People's Hospital — Qingyuan, Guangdong, China (Not_yet_recruiting)
- People's Hospital of Yingde — Qingyuan, Guangdong, China (Not_yet_recruiting)
- Zhuhai Golden Bay Central Hospital — Zhuhai, Guangdong, China (Not_yet_recruiting)
- Ganzhou Municipal Hospital — Ganzhou, Jiangxi, China (Not_yet_recruiting)
Study contacts
- Principal investigator: Feng Wen, MD — Guangdong Provincial People's Hospital
- Study coordinator: Xueqing Yu, MD
- Email: yuxueqing@gdph.org.cn
- Phone: +86-20-83827812
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.